Biomimetic Nanoparticles for Metastatic Breast Cancer: Advancing Targeted Drug Delivery Beyond Conventional Nanomedicine.
Breast cancer remains a leading cause of cancer morbidity and mortality worldwide. Although nanomedicines are a promising and rapidly evolving therapeutic platform, their clinical translation remains limited. Depending on the stage and subtype of the disease, systemic treatments and localized strategies are still essen...